PF-06882961 Uses, Dosage, Side Effects and more
PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus).
| Trade Name | PF-06882961 |
| Generic | PF-06882961 |
| Type | |
| Formula | C31H30FN5O4 |
| Weight | Average: 555.61 Monoisotopic: 555.228182629 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
